FDA Warning Letter — Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd. on Oct 30, 2024 (Tianjin, China). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.
- Date
- Oct 30, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Tianjin (China)